Safety and BNT162b2 mRNA COVID-19 vaccination

Beuy Joob; Viroj  Wiwanitkit

doi:10.23750/abm.v92i6.12359

Safety and BNT162b2 mRNA COVID-19 vaccination

Authors

Beuy Joob Sanitation 1 Academic Center, Bangkok, Thailand
Viroj Wiwanitkit Honorary professor, Dr DY Patil University, Pune, India

DOI: https://doi.org/10.23750/abm.v92i6.12359

Keywords:

safety, covid, vaccine

Abstract

n/a

References

Vigezzi GP, Lume A, Minerva M, Nizzero P, Biancardi A, Gianfredi V, Odone A, Signorelli C, Moro M. Safety surveillance after BNT162b2 mRNA COVID-19 vaccination: results from a cross-sectional survey among staff of a large Italian teaching hospital. Acta Biomed [Internet]. 2021 Oct. 1 [cited 2021 Oct. 4];92(S6):e2021450.

Mishra S, Mungmunpuntipantip I. Editorial: a good case report that might not be accepted for publication in a journal. Case Study Case Rep. 2021; 11(3): 32 - 33.

Downloads

Published

19-01-2022

Issue

Vol. 92 No. 6 (2021)

Section

E-LETTERS: COMMENTS AND RESPONSES

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

How to Cite

Joob B, Wiwanitkit V. Safety and BNT162b2 mRNA COVID-19 vaccination. Acta Biomed. 2022;92(6):e2021485. doi:10.23750/abm.v92i6.12359

Download Citation